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Abstract Background: The death 
of growth and development 
screening tools in developing 
countries has grave implications 
for child health outcomes. The 
aim of the study was to determine 
the effectiveness of a novel 
screening tool in a rural Nigerian 
community.  
Method: Speech and language, 
Motor, Appearance and Tempera-
ment (SMAT) parameters of un-
der-fives were queried using a 
novel tool, the SMAT Score. The 
effectiveness of the tool was as-
sessed in three phases. In the first 
two phases the tool was adminis-
tered to 210 under- fives 
(Subjects) independently. Those 
screened as having anomalies are 
classified as NOT SMAT while 
those screened otherwise as 
SMAT. In the third phase all NOT 
SMAT subjects and a number of 
randomly selected SMAT subjects 
were clinically evaluated. Out-
comes of SMAT Score admini-
stration and clinical evaluation 
were subjected to psychometric 
assessments. 
Results: There were 210 subjects 
with age range of 0.5 to 4.9 years 
(mean 2.3 ± 1.3 years) studied. Out 
of these 34 (16.2%) were screened 
as NOT SMAT. All the 90 
(51.1%) randomly selected SMAT 
subjects as against 1 (2.9%) of the 
NOT SMAT subjects were clini-
cally evaluated as normal. Inter 
rater and test – retest agreement 
rate in SMAT Score administrators 
was 100%. SMAT Score sensitiv-
ity and negative predictive value 
was 100% respectively in all age 
groups. The specificity was 98.9% 
overall and 96.3% among infants. 
Higher SMAT Score positive pre-
dictive value (97.1%) was ob-
served with the entire study popu-
lation as against 87.5% among 
infants. 
Conclusion: SMAT Score effec-
tively identified subjects with 
growth and developmental disor-
ders. Its use has potential for im-
proving health systems and conse-
quently child health outcomes in 
developing countries. 
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Introduction 
 
Growth and developmental disorders are significant o -
tributors to childhood, particularly under-five, morbidity 
and mortality in developing countries.1–3 Early identifi-
cation of childhood disorders has been reported to im-
prove child health outcomes.4,5 The regular assessment 
or monitoring of childhood growth and development, 
particularly of those at risk such as the under-fives, 
would facilitate improvement in the outcome of growth 
and developmental disorders. 
 
While there is a plethora of growth and developmental 
screening tools in the developed countries, 6,7 there is a 
dearth of such tools in their under developed  
counterparts.8–10 Even where these tools are available 
their use is limited by cost of accessing the tools, social-
cultural diversity that affect validity, and poor  
knowledge of tool administration. The measures taken in 
the past to obviate these limitations, such as tools valida-
tion for local use and creation of culturally sensitive 
development assessment tools, have met with functional 
limitations.8–13 
 
The SMAT Score is a screening tool, designed by the 
author, which assesses multiple growth and develop-
ment domains using conventional methods. The aim of 
the study was to determine the effectiveness of this tool 
in identifying under-fives with growth and developmen-
tal disorders in a rural Nigerian community.  
Method 
Study area 
 
The study was conducted in the Katari North District of 
Kachia Local Government Area (L.G.A.) and the 44 
Nigeria Army Reference Hospital in Kaduna South 
L.G.A. both in Kaduna State, Northwestern Nigeria. 
Kachia L.G.A. was selected through a simple random 
selection from the 23 LGAs that make up Kaduna State, 
one of the 36 states and the Federal Capital Territory 
that constitute Nigeria. The Katari North district was 
also selected through a simple random selection from 
the 24 districts in Kachia Local Government Area. It has 
an estimated population of 3,500 persons who are 
mainly subsistence farmers and petty traders. 14 Admin-
istratively the district is headed by a District Head who 
is assisted by the Village Heads of the 20 villages that 
make up the district. Health care delivery is made vail-
able through a Primary Health Care Centre, a private 
hospital owned by a faith based organization and a gov-
ernment owned General Hospital 30km away. Main  
languages spoken are Hausa, Adara and Pidgin English.  
The 44 Nigerian Army Reference Hospital Kaduna (44 
NARHK) is a tertiary health institution located in the 
state capital and approximately 100 kilometers from 
Katari. It renders specialist health services to military 
personnel and the civilian population in Kaduna andits 
environs. The hospital is an accredited centre for p st 
graduate medical training by the National Postgraduate 
Medical College of Nigeria and the West African Post-
graduate Medical College. The department of Paediat-
rics offers both out and in patient clinical services. It has 
a total of 16 beds and its medical staff comprises of two 
Consultant Paediatricians, one medical officer and,  
residents and interns rendering service and undergoing  
various stages of training. SMAT Score (Table 1) 
 
Table 1. SMAT Score          
1. Identification Number……..……………………………. 
2. Name………………….…..3. Informant...........................  
4. Address…...…………………………………………………. 
5. Age (Years)……… 6.Sex…… 7. Height/length (H/L)….cm 
8. Weight (W)……..…… kg    9.Occipito–Frontal–
Circumference (OFC)………….........cm 
 
10. PARAMETER                    RESPONSE (CIRCLE) 
 
A. SPEECH – LANGUAGE                                 YES   NO                   
I. Is it present                 1  0 
II. Is it normal                 1  0 
III. Is current status appropriate for age            1  0 
 
IV.             SUB TOTAL SCORE…………….. 
 
B. MOTOR     
    
I. Is it present                                  1  0 
II. Is it normal                                  1  0 
III. Is current status appropriate for age            1  0 
 
IV.             SUB TOTAL SCORE…………….. 
 
C. APPEARANCE 
I. No absence in form                              1 0 
II. No abnormality in form                1  0 
III. Is current physical status (H/L, W, OFC)  
                          appropriate for age       1  0  
 
IV.             SUB TOTAL SCORE……………..   
 
D. TEMPERAMENT AT ACTIVITY* MOST TIMES       
                  HIGH    ODERATE   LOW 
 
I.   Level of motor involvement in activity 1 1 0 
II.  Mood level during activity  1            1            0 
III. Energy level during activity  1            1              0 
IV. Level of change in activity needed  
       for response                     0            1                1 
V.   Adaptability to new activity  1            1             0 
VI.  Role completion in activity      1         1               0 
VII. Role completion despite interference 1 1      0 
VIII. Response to new activity    1          1               0 
IX.   Regularity at activity                          1                1          1 
 
X.              SUB TOTAL SCORE……………….  
   
11. TOTAL SCORE= A.IV + B.IV + C.IV + D.X 
 
ACTIVITY *(FEEDING for those≤ one year of age or PLAY for 
those˃  one year of age)  
12. ASSESSMENT OUTCOME: ……………………...….. (SMAT if 
total score=18 and NOT SMAT if total score ˂18) 
 
13. Assessed by …………………….  14. Date ……………………… 
 
The SMAT Score, conceived and developed by the au-
thor, assesses three developmental domains and physical 
growth. The assessed parameters, from which the acro-
nym SMAT is derived from, are Speech and language, 
Motor, Appearance (representing physical growth) and
Temperament. Administration of the tool involves both 
caregiver’s and tool administrator’s assessment of a 
child’s growth and development. 
 
SMAT Score parameters: 
a. Speech and language 
 
This parameter is assessed through queries in three  
sections. These include: 
i. The first query, directed at the caregiver, asks about 
the presence or absence of speech and/or language. 
The expected response is ‘Yes’ or ‘No’. 
ii. The second query, also directed at the caregiver, 
asks whether the development of speech and/or lan-
guage has been normal. The expected response is 
also a ‘Yes’ or ‘No’. 
iii. The third query, directed at the tool administrator, 
determines the relationship between the child’s state 
of speech and language development and that of its 
peers. To achieve this, the child state of develop-
ment is compared with that of its peers using a con-
ventional standard. 15 the expectations in this stan-
dard is similar to that expected of Nigerian chil-
dren.16 The expected response to the query, after 
assessment, is a ‘Yes’ or ‘No’. 
 
b. Motor (Motor function development) 
 
The queries are similar to those in the speech and l -
guage parameter and they include: 
i.   Query about the presence of motor function in the
child and directed at the caregiver with an expected 
response of ‘Yes’ or ‘No’. 
ii. Query about the presence of any observed abnor-
mality in motor function of the child directed at the 
caregiver with an expected response of  
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      ‘Yes’ or ‘No’. 
iii. The third query is directed at the tool administrator 
and questions the relationship between the child’s 
state of motor function development and that of its 
peers. The child’s state of development is compared 
with that of its peers using a summary of the World 
Health Organization motor milestones development 
standards and a more comprehensive conventional 
standard.17,18 The WHO standard is universal but 
limited to six major milestones and children less 
than two years of age. The milestones in the con-
ventional standard are more encompassing and 
similar to those expected of Nigerian children.16,18 
The expected response to the query, after assess-
ment, is a ‘Yes’ or ‘No’. 
 
c. Appearance (Physical growth) 
 
In this parameter growth is assessed through queries 
about the physical attributes of the child. 
i.  The first query, directed at the caregiver, questions 
the presence of any deficit in the physical attributes 
specifically the absence or lack of formation of any 
physical structure of the body. The expected re-
sponse is ‘Yes’ or ‘No’. 
ii. The second query, also directed at the caregiver, 
questions the presence of any abnormality in the 
form of the child’s physical structure specifically 
the presence of dysmorphic features in the child. 
The expected response is ‘Yes’ or ‘No’. 
iii. The third query, directed at the tool administrator, 
questions the current state of development of the 
child’s physical attributes by comparing the child’s 
current anthropometric measurements of Height, 
Weight and Occipito-Frontal-Circumference with 
that of its peers. The comparative conventional stan-
dard is the 2006 World Health Organization growth 
standards. 19,20All measurements less than -2 z 
scores or greater than 2 z scores for age and sex are 
regarded as abnormal. The expected response after 
assessment is a ‘Yes’ or ‘No’. 
 
d. Temperament 
 
This parameter assesses the behavioral responses of a 
child to a common childhood activity. The two child-
hood activities queried in SMAT Score are Feeding ad
Play. The behavioral queries were developed, by the 
author, along the temperamental characteristics of Th -
mas and Chess.18,21 The queries are directed at the care-
giver and concern the child’s behavioral responses mo t 
of the times and during feeding or play to the character-
istics of activity level, adaptability, approach and with-
drawal, attention span and persistence, distractibility, 
intensity of reaction, quality of mood, rhythmicity and 
threshold of responsiveness. The responses are gradd as 
High, Moderate or Low reflecting both the intensity and/
or frequency of the behavioral characteristics most of 
the times with emphasis on ‘most of the times’ presenta-
tion. 
 
During the SMAT Score pre test, three common child-
hood activities namely feeding, play and sleep were con-
sidered for assessment in the temperament parameter of 
SMAT Score. In the course of the pre test it was ob-
served that in children between the ages of six months 
and one year of age caregivers provided comparatively 
more information, relevant to the temperament parame-
ter, about feeding than during play or sleep. Also, for 
children between the ages of one and five years more 
relevant information was available concerning play than 
feeding or sleep. Consequently feeding and play were 
the assessed activities for children aged less thanone 
year and those between one and five years respectively. 
 
SMAT Score scoring 
 
For the parameters of Speech and language, Motor func-
tion and Appearance a ‘Yes’ response scores one point
while a ‘No’ response scores zero. Consequently for 
each of these parameters the maximum score is three
points and the minimum is zero. For the parameter of 
Temperament, every ‘High’ grade scores one point ex-
cept in the characteristic ‘Level of change in activity 
needed for response’ which scores zero. Thus the maxi-
mum score in the ‘High’ grade is eight. The ‘Moderat ’ 
grade scores one point for all characteristics givin  a 
maximum score of nine. The ‘Low’ grade scores zero 
for all characteristics except for the characteristics of 
‘Regularity at activity’ and ‘Level of change in activity 
need for response’ making two points the maximum 
recordable score for this grade. In total Temperament 
has maximum and minimum recordable scores of nine 
and two respectively. Overall a normal SMAT Score is 
the outcome when a child scores maximum scores in all
four parameters assessed. A child that scores the maxi-
mum score of 18 is referred to as SMAT Score positive 
or SMAT. Conversely any child who scores less than 18 
is referred to as SMAT Score negative or NOT SMAT. 
A child who is SMAT Score negative or NOT SMAT 
would require a further clinical evaluation.  
 
 SMAT Score administration 
 
To administer SMAT Score in the study, two English 
and Hausa Languages speaking Community Health Ex-
tension Workers (CHEWS) were recruited and trained 
by the author on the content and how to administer 
SMAT Score as a screening tool. Prior to commence-
ment of the study a pretest was conducted in a commu-
nity with characteristics similar to Katari. The commu-
nity, the Rido community, is located approximately 
85km from Katari. Also a translation and back transl -
tion of SMAT Score from English to Hausa Language, 
the commonly spoken language in the pretest and study 
communities, was carried out during the pretest. It takes 
15 to 20 minutes to administer SMAT Score. 
 
Sample size determination 
  
The estimated prevalence of the under-five population in 
Nigeria is 16.8%.22 This prevalence was used in calcu-
lating the under-five population size for this study. Con-
sequently with a prevalence of 17%, a confidence lev l  
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of 95% and allowing for a 5% margin of error a sample 
population sample size of 211 was calculated. However 
considering that the study population is less than 10,000 
persons, the sample population was readjusted to 210 
under-fives. 
 
Inclusion criteria 
 
Included in the study were all under-fives, referred to as 
Subjects, residing in Katari Community and who have  
verifiable birth date made available through birth e-
cords or corroborative oral evidence. 
 
Exclusion criteria 
 
Excluded were Subjects who did not fulfill the inclusion 
criteria and those who had a current illness requiring 
immediate medical attention. The need for intervention 
in such cases could influence participation and outcome 
of the study. 
 
Conduct of study 
 
The study was conducted between September and De-
cember 2012. Ethical approval was obtained from the 
Research Ethics Committee of 44 NARHK and consent 
obtained from the district head, respective village heads 
and heads of every participating household before cm-
mencement of the study. 
 
The study was conducted in three phases. The first and 
second phases were conducted in Katari Community. 
The 20 villages were enumerated and a village selected 
for study through a simple random selection. From the 
house of the village head an axis is randomly select d 
and all eligible Subjects in households along a select d 
axis are studied. If the households along a selected axis 
are exhausted and the sample size not met, there is a 
return to the house of the village head and a new axis to 
be studied along randomly selected. If a village is stud-
ied and the study sample size is yet to be attained an-
other village is randomly selected and the study process 
repeated until the sample size was attained.   
 
In the first phase SMAT Score was administered by the 
trained administrators, to the same caregivers and their
respective Subjects, independently and simultaneously. 
The administrators took all anthropometric measure-
ments and assessed all comparative responses with the 
derived conventional standards. Height was measured 
using a stadiometer for those who could stand erect and 
to the nearest 0.1cm while recumbent length, using a  
adjustable calibrated flat board, was measured in those 
who could not stand or were yet to achieve the mile-
stone. Weight was measured to the nearest 0.1kg and 
using a standing weighing scale for those who could 
stand and a bassinet weighing scale for those who could 
not or had not achieved the milestone. The OFC was 
measured using a non stretchable but flexible tape meas-
ure. The tape measure is applied across the frontal bone 
anteriorly and the occipital bone posteriorly along the 
widest possible diameter and measurement taken to the 
nearest 0.1cm. Each growth parameter was measured 
twice by the tool administrator, at the beginning ad end 
of the tool application, and the average measurement 
recorded as the measurement for that parameter.   
SMAT Score was re administered, three weeks later, by 
the same administrators to the same caregivers and Sub-
jects in the second phase of the study. The third phase 
was conducted at 44 NARHK. In this phase all NOT 
SMAT Subjects and at least half of the SMAT Subjects, 
randomly selected, were evaluated clinically in the pa -
diatric outpatient clinic of 44 NARHK by a consultan  
paediatrician. All those diagnosed as having a medical 
disorder were treated and managed accordingly in the 
department of paediatrics. 
 
Data analysis 
 
SMAT Score was analyzed for inter rater, test retest and 
validity outcomes. Chi-square test, with Yates’ correc-
tion were appropriate, was used for assessing the signifi-
cance of validity differences in the age groups. A p 
value less than 0.05 was regarded as significant. 
 
 
 
Results 
 
A total of 210 Subjects were assessed using SMAT 
Score. They had an age range of 0.5 to 4.9 years (mean 
2.3±1.3years) and a male preponderance 123(58.6%). 
Out of the total number assessed, 34(16.2%) were idn-
tified as NOT SMAT. Their age range was 0.5 to 4.3 
years (mean 2.1±1.3years) and had a male preponder-
ance (18, 52.9%) as well. Table 2 shows the age and sex 
distribution of the 210 Subjects and the 34 NOT SMAT 
Subjects. 
 
Table 2: Age and sex distribution of the 210 assessed and 34 
NOT SMAT Subjects 
Inter rater reliability 
 
There was no difference in the outcome of the assess-
ment by the two SMAT Score assessors in the first 
phase of the study. Both identified the same Subjects 
and number that were NOT SMAT. 
 
Test retest reliability 
 
The repeat assessment of the study population in the 
second phase of the study by the same assessors yielded  
Age 
(years) 
 All assessed Subjects (%) 
           Sex 
    M                  F          Total 
NOT SMAT Subjects (%) 
          Sex 
  M               F       Total 
%of 
Total 
≤1 21 
(17.1) 
13 (14.9)   34(16.2) 4(22.2)   4(25)      8(23.5) 13.1 
1.1–2 35 
(28.4) 
26 (29.9)   61(29) 7(38.9)   6(37.5)   13(38.2) 38.1 
2.1–3 31 
(25.2) 
19 (21.8)   50(23.8) 1(5.5)     3(18.8)    4(11.8) 28.6 
3.1–4 
4.1–5 
14 
(11.4) 
22
(17.9) 
17 (19.5)   31(14.8) 
12(13.8)    34(16.2) 
3(16.7)   1(6.2)      4(11.8) 
3(16.7)   2(12.5)    5(14.7) 
20.2 
Total 123    87                210    18           16            34 100 
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the same outcomes. The same Subjects and number  
(34, 16.2%) were identified as NOT SMAT. 
 
Validity 
 
All the 90 randomly selected SMAT Subjects were as-
sessed as normal after clinical evaluation in the depart-
ment of paediatrics, 44 NARHK. Out of the 34 NOT 
SMAT Subjects, only 1(2.9%) was clinically evaluated 
as normal. The Subject that was evaluated as clinica ly 
normal is a seven month old male whose SMAT Score 
was 16. The SMAT Score abnormality was observed in 
the Temperament parameter in which LOW MOST 
TIMES (score of 0) response to the queries about re-
sponse and adaptation to a new activity (feeding) was 
indicated respectively. This singular finding among the 
infants compared to none in the older children was not 
significant (χ2=0.40, df=1, p=0.526). Table 3 shows the 
validity estimates of SMAT Score. 
 
Table 3: Estimates of SMAT Score validity in clinically 
evaluated 90 SMAT and 34 NOT SMAT Subjects 
Under nutrition seen in 13(39.4%) of the 33 Subjects 
with a clinical diagnosis was the commonest childhood 
disorder (Table 4). The least common disorder was 
physiologic stereotypy diagnosed in a 10 month old 
male who presented with a two month history of re-
peated head nodding without any other co-morbidity. 
 
Table 4: Outcome of the clinical evaluation of 33 NOT SMAT 
Subjects  
 
 
 
Discussion 
 
SMAT Score recorded absolute inter rater and test-retest 
agreement outcomes in this study. Its high sensitivity 
and specificity outcomes are comparable to that of  
Variable All  
Subjects 
  
Subjects 
≤ 1 year 
Subjects 
˃1 year 
Sensitivity(a/a+c x 100) 
Specificity(d/b+d x100) 
Positive Predictive Value
(a/a+b x100) 
Negative Predictive Value
(d/c+d x100) 
100 
98.9 
97.1 
 
100 
100 
96.3 
87.5 
 
100 
100 
100 
100 
 
100 
a=true positives  b=false 
positives c=false negatives  
d=true negatives 
 
  
  
 
  
  
 
  
  
 Childhood disorder                                                                                                                                                                                                                           No of Subjects Percent of
Total 
Under nutrition 13 39.4 
Rickets 6 18.2 
Sickle Cell Anemia 4 12.1 
Cerebral palsy 4 12.1 
Stuttering 3 9.1 
Expressive Language Disorder 2 6.1 
Physiologic Stereotypy 
Total 
1 
33 
3 
100 
contemporary growth and development screening tools. 
Even though SMAT Score specificity was lower in in-
fants, all psychometric outcomes met requirements for 
standard screening test accuracy.7 The tool also demon-
strated remarkable ability to screen out children with 
mild to severe disorders of growth and development. 
 
Modalities for assessing or monitoring growth and  
development in developing countries are variable. They 
include use of assessment tools from the developed 
countries, 23 locally developed tools, the Road To Health 
Card (RTHC), 24–26 and routine clinical evaluation dur-
ing hospital visits. Generally there is a dearth of assess-
ment tools, particularly those concerning development, 
in developing countries. While high cost of procure-
ment, lack of knowledge about the existence and appli-
cation of these tools contribute to the scarcity of tools 
from the developed countries, paucity of research into
child development as reported by Ertem and colleagus9 
is a constraint to tool development in the in developing 
countries. 
 
Where tools from the developed countries are available, 
socio cultural differences between the two worlds and 
very robust construct content throw up validity issue . 
Gladstone and colleagues23 observed several items on 
social development in assessment tools from developed 
countries performing poorly in a typical developing 
country setting. The content of the construct of some 
assessment tools are so extensive such that the benefit of 
shortening them have been explored even in the devel-
oped countries. The Very Short Form of the Children’s 
Behavior Questionnaire (CBQ-VSF) was recently psy-
chometrically evaluated and limited validity was found 
for the extracted factors and the external constructs.27 
Validity could have been more limited in an under d-
veloped setting. Consequently limited validation is ob-
served with most of these tools. Limited validation a d 
application of the tools make it difficult to appreciate the 
impact of these tools on child development in develop-
ing countries. 
 
Assessment tools such as the Guide for Monitoring 
Child Development (GMCD),9 the Malawi Development 
Assessment Tool (MDAT),10 the Ten Questions Ques-
tionnaire (TQQ),11,12 and the Disability Screening 
Schedule (DSS)13 are some recent tools that have been 
designed in developing countries. However there are 
reported limitations of these tools which restrict their 
application or impact. The validity of the GMCD though 
remarkable was obtained in a clinical research setting 
questioning the possibility of similar outcomes in popu-
lation based samples,9 the MDAT was developed using a 
select group of Malawian children as standard with lim-
ited applicability,10 the TQQ and DSS have been re-
ported to having a tendency of identifying only children 
with severe disabilities and not having a frame work f  
monitoring the development of young children.11-13 
 
The RTHC is widely available in developing coun-
tries.24,25 It documents information about a child’s socio- 
demographic characteristics, immunization history,  
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feeding practices as well as growth and developmental 
advances in charts. The focus, in this card, being o  
documentation rather than assessment can be implied 
from the RTHC’s under utilization as a growth and  
development assessment tool.25 This short coming is 
likely enhanced by the restricted number of growth and 
developmental domains indicated for assessment in 
these cards. The restriction limits caregiver participation 
in assessment and obscures the training needs of the 
health worker filling these cards. These increase the risk 
of not identifying early a significant population of chil-
dren with growth and developmental anomalies. The use 
of clinical evaluation as a screening tool, in developing 
countries, is impracticable considering the scarcity of 
human and health care resources.28 
 
SMAT Score recorded high sensitivity and specificity 
outcomes for a growth and development assessment 
tool.7 The outcomes were as remarkable as findings from 
other environmentally sensitive assessment tools, such 
as the GMCD and MDAT, proposed for use in 
LMICs.9,10 Consequently SMAT Score has immense 
prospect as a tool for effective identification of those 
who have or are at risk of having growth and develop-
ment anomalies in early childhood. This could have  
significant impact on child health services in the country 
and other LMICs that do not have a model for promo-
tion and monitoring of child development.29 SMAT 
Score equally recorded a high concurrent validity out-
come. This attribute of SMAT Score and its ease of ap-
plication underscore its potential in augmenting child 
health services particularly in settings where skilled 
manpower and equipment for identifying growth and 
development anomalies are either scarce or not avail-
able. SMAT Score also displayed the capacity of detect-
ing growth and developmental anomalies in a wide 
range of disorders with varying prevalence, severity and 
etiology. It was able to identify these anomalies in a 
potentially serious condition like under nutrition, a se-
vere condition like cerebral palsy and a genetic disorder 
like sickle cell anemia. The capacity for facilitatng early 
detection of these conditions and other potentially grave 
childhood disorders signify great potential for SMAT 
Score in strengthening child health services particularly 
with its incorporation into well child health visit and 
school health services. Furthermore, the age range for 
which SMAT Score is applicable makes it a valuable 
tool for the monitoring of early childhood growth and 
development.29 
 
The characteristics of an effective growth and develop-
ment screening tool, in developing countries, were aptly 
described by Ertem and colleagues.9 They highlighted 
that such a tool must be based on and supported by stan-
dard theories of child development, be reliable and 
valid, have capacity for supporting and managing devel-
opmental frame works, should be easily applicable and 
at a minimal cost.9 The SMAT Score is based on stan-
dard theories and universal standards. This reduces the 
need to standardize and validate across countries. More-
over the tool adds to contemporary growth assessment 
by appraising the presence or otherwise of physical  
deficits. It also provides another platform of exploring 
behavioral responses to common childhood activities. 
SMAT Score has shown remarkable reliability and  
validity in a population based sample. Its potential in 
developing caregiver perception and participation in 
screening assessments in addition to developing the  
assessment capacity of the health worker strengthens the 
health care system. Application of SMAT Score  
required administrators with basic qualification in health 
care delivery, simple administrative materials and was 
easily administered in a rural population. These attrib-
utes suggests a minimal cost and a cost effective ben fit 
to the health care system. The characteristics exhibited 
by SMAT Score in this study underscore its relevance 
and that of tools like it in child health care deliv ry par-
ticularly in developing countries. 
 
A limitation in the use of SMAT Score was highlighted 
in the discrepancy between clinical evaluation and tem-
peramental assessment in the respective infant. Care-
giver understanding or expectation rather than the actual 
temperamental status could be the response to queries in 
a parameter. This can be reduced by providing adequat  
caregiver enlightenment and emphasizing the need to 
giving appropriate responses to queries. Also there are 
complexities associated with growth and development in 
very young children which could limit the outcome of 
SMAT Score. These complexities include the challenge 
associated with quantifying all inherent variations, in 
growth indices and motor functions of very young chil-
dren, in a normal population and being able to account 
for all of them in an established standard. This wahigh-
lighted by Gorter and colleagues in a study concerning 
classification of motor function in very young children 
with cerebral palsy.30 Also complex is the extrication of 
the impact of a variable in a developmental domain from 
the assessment of another related variable. For instance 
observation of a low most times response to a new activ-
ity (feeding) in this study could be the product of a nor-
mal positive psychological influence such as attachment 
on development. 
 
SMAT Score, the limitations notwithstanding, has 
shown relevance and standard psychometric properties 
in a population based sample of under-fives. Its incorpo-
ration into health care delivery through affiliation with 
maternal and newborn health initiatives, school healt  
programs and community based health initiatives would 
broaden the scope of health services coverage. The train-
ing of all health workers and health allied workers, such 
as school health teachers, on the SMAT Score and its 
application would help develop service delivery capacity 
in the health sector.  Also establishment of a SMAT 
Score data bank, in the health monitoring units at all 
levels of health care delivery, to document and commu-
nicate the outcomes of periodic evaluation of children 
would facilitate dissemination of health information 
within health systems. Consequently SMAT Score has 
the potential of strengthening health care systems and as 
a result would improve child health outcomes in devel-
oping countries. However, further insight into the effec-
tiveness of this tool would be served by more studies in  
12 
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